Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

KOS vs VET: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

VET Wins Head-to-Head Institutional Verdict (3–3 across 6 Pillars · 7–3 Matrix Metrics)

VET Overall Winner 6-Pillar Tally: KOS 3 – 3 VET Matrix Metrics: KOS 3 – 7 VET

As of Nov 20, 2026, Vermilion Energy Inc. (VET) is the stronger overall head-to-head candidate over Kosmos Energy Ltd. (KOS) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Profitability & Quality, Balance Sheet & Cash Flow, Options & Positioning). KOS carries a Unified Composite Score of 40.8/100 (SELL) at $1.65 (4.9x Forward P/E, -8.8% operating margin), whereas VET carries 71.1/100 (BUY) at $10.25 (17.4x Forward P/E, -0.7% operating margin).

  • Technical & Structure Timing Caution: KOS is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 26.6); meanwhile VET is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 33.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About KOS vs VET
KOS NYSE
Kosmos Energy Ltd.
Crude Petroleum & Natural Gas
$1.65
-2.94% 1D
Market Cap $1.0B
TTM Revenue $1.68B
Forward P/E 4.9x
Beta / 30D Vol -1.27β · 91% Vol
Unified Composite Score
40.8 / 100 SELL
Tech 25.0 Fund 46.0 Flow 58.0 Mom 55.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -8.2%), weak momentum, RSI 27
RSI-14: 26.6 · SMA20: $2.27 · SMA50: $2.53
VET NYSE Head-to-Head Winner
Vermilion Energy Inc.
Crude Petroleum & Natural Gas
$10.25
-1.06% 1D
Market Cap $1.6B
TTM Revenue $1.97B
Forward P/E 17.4x
Beta / 30D Vol -0.77β · 61% Vol
Unified Composite Score
71.1 / 100 BUY
Tech 84.0 Fund 71.0 Flow 56.0 Mom 70.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -3.7%), weak momentum, RSI 33
RSI-14: 33.5 · SMA20: $11.53 · SMA50: $12.01

6-Pillar Scorecard Institutional Category Breakdown (KOS 3 – 3 VET)

Columns: Metric · KOS · VET
1. Valuation Multiples KOS
Forward P/E 4.9x 17.4x
Trailing P/E 3.0x 17.4x
PEG Ratio N/M 3.58x
EV / Revenue 2.1x 1.4x
2. Growth & Scale KOS
Revenue Growth (YoY) +31.8% +30.4%
Earnings Growth (YoY) -50.0% -94.9%
TTM Revenue (USD) $1.68B $1.97B
Market Cap $1.0B $1.6B
3. Profitability & Quality VET
Gross Margin 66.6% 64.0%
Operating Margin -8.8% -0.7%
Net Profit Margin -27.4% -24.6%
Return on Equity (ROE) -58.8% -20.1%
4. Balance Sheet & Cash Flow VET
Cash Generation (TTM) $183M $1.31B
Cash Flow Margin 10.8% 66.5%
Net Cash / Leverage $2.55B Net Debt (3.96x D/E) $1.18B Net Debt (0.59x D/E)
Dividend Yield None (0.00%) 5.20%
5. Options & Positioning VET
Options Structure Phase BREAKDOWN CONSOLIDATION
Current IV / %ile 82.6% (22nd %ile) 46.5% (23rd %ile)
Put/Call OI Skew 0.96x (Balanced) 0.30x (Call-Skewed)
OBV Trend / Tech Phase DISTRIBUTION · Markdown NEUTRAL · Markdown
6. R&D & Supply-Chain Moat KOS
OpEx & R&D Intensity 75.4% of Rev ($1.27B) 64.7% of Rev ($1.27B)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Oil & Gas E&P Operator Oil & Gas E&P Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: KOS (3) vs VET (7)
Institutional Metric KOS VET Criterion Row Edge
Market Capitalization
Scale
$1.0B $1.6B Larger Scale VET
Trailing P/E Ratio
Valuation
3.0x 17.4x Lower Multiple KOS
Forward P/E Ratio
Valuation
4.9x 17.4x Lower Multiple KOS
Revenue Growth (YoY)
Growth
+31.8% +30.4% Higher Growth KOS
Operating Margin (TTM)
Profitability
-8.8% -0.7% Higher Margin VET
Net Profit Margin
Profitability
-27.4% -24.6% Higher Margin VET
Return on Equity (ROE)
Capital Efficiency
-58.8% -20.1% Higher ROE VET
52-Week Range Position
Momentum
32% ($1–$3) 35% ($8–$15) Stronger Trend VET
Beta / 30D Volatility
Risk Regime
-1.27β · 91% Vol -0.77β · 61% Vol Lower Realized Risk VET
Unified Institutional Score
Composite Signal
40.8 / 100 (SELL) 71.1 / 100 (BUY) Higher Composite VET
Trailing 12M Revenue (USD)
Operating Scale
$1.68B $1.97B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
66.6% 64.0% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 2.1x EV/Rev 3.58x PEG · 1.4x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$183M ($2.55B Net Debt (3.96x D/E)) $1.31B ($1.18B Net Debt (0.59x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon VET +15.1 pp
KOS: -38.89% · VET: -23.79%
3M Horizon VET +24.05 pp
KOS: -42.31% · VET: -18.26%
6M Horizon VET +28.87 pp
KOS: -45.54% · VET: -16.67%
1Y Horizon KOS +12.77 pp
KOS: +24.06% · VET: +11.29%

Financial Trajectory Annualized Quarterly Run-Rate Revenue & Operating Margin Trajectory (USD-Normalized)

Split-Invariant USD Revenue & Operating Margin (%)
Period KOS Revenue VET Revenue KOS Op. Margin VET Op. Margin Margin Leader
Q3 '25 $1.24B $1.86B -14.8% 6.7% VET
Q4 '25 $1.18B $1.85B -56.4% -0.8% VET
Q1 '26 $1.48B $2.08B 19.6% 19.6% Tie
Q2 '26 $2.43B $2.25B 46.9% 23.9% KOS
Q3 '26 $1.64B $2.44B 42.2% 25.8% KOS

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
KOS BREAKDOWN
140d in phase · OBV DISTRIBUTION
Current IV 82.6%
IV Percentile 22nd %ile
Put/Call OI Skew 0.96x (Balanced)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow DISTRIBUTION
Exact KOS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
VET CONSOLIDATION
48d in phase · OBV NEUTRAL
Current IV 46.5%
IV Percentile 23rd %ile
Put/Call OI Skew 0.30x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact VET Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
KOS Moat Profile Cyclical / Execution-Driven Positioning
Oil & Gas E&P Operator
Competes within the Oil & Gas E&P value chain with $1.0B market capitalization and -8.8% operating margin.
OpEx & R&D Reinvestment 75.4% of Rev ($1.27B)
90D Engineering Disclosures 0 Published
VET Moat Profile Cyclical / Execution-Driven Positioning
Oil & Gas E&P Operator
Competes within the Oil & Gas E&P value chain with $1.6B market capitalization and -0.7% operating margin.
OpEx & R&D Reinvestment 64.7% of Rev ($1.27B)
90D Engineering Disclosures 0 Published

Investor FAQ KOS vs VET Key Questions & Quantitative Answers

As of Nov 20, 2026, Vermilion Energy Inc. (VET) is the stronger overall head-to-head candidate over Kosmos Energy Ltd. (KOS) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Profitability & Quality, Balance Sheet & Cash Flow, Options & Positioning). KOS carries a Unified Composite Score of 40.8/100 (SELL) at $1.65 (4.9x Forward P/E, -8.8% operating margin), whereas VET carries 71.1/100 (BUY) at $10.25 (17.4x Forward P/E, -0.7% operating margin). Technical & Structure Timing Caution: KOS is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 26.6); meanwhile VET is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 33.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

KOS leads the Growth & Scale pillar: KOS posts +31.8% YoY revenue growth and -50.0% YoY earnings growth on $1.68B TTM revenue (66.6% gross margin, -8.8% operating margin), compared with VET at +30.4% YoY revenue growth and -94.9% YoY earnings growth on $1.97B TTM revenue (64.0% gross margin, -0.7% operating margin). Across the 5-period historical trajectory (Q3 '25 to Q3 '26), KOS cumulative revenue shifted +32.3% while VET shifted +31.2%. In operating R&D and SG&A reinvestment, KOS deploys 75.4% of Rev ($1.27B) (0 90-day corporate R&D disclosures) versus 64.7% of Rev ($1.27B) (0 disclosures) for VET.

KOS screens cheaper on headline valuation multiples. KOS trades at 4.9x Forward P/E, 3.0x Trailing P/E, N/M PEG, and 2.1x EV/Revenue (10.8% FCF margin), whereas VET trades at 17.4x Forward P/E, 17.4x Trailing P/E, 3.58x PEG, and 1.4x EV/Revenue (66.5% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against KOS (-58.8% ROE) versus VET (-20.1% ROE) capital efficiency.

In options market volatility and institutional positioning, KOS carries 82.6% implied volatility (22nd %ile, Compressed (<25th %ile)), a 0.96x (Balanced) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (-1.27β · 91% Vol realized risk). By comparison, VET carries 46.5% implied volatility (23rd %ile, Compressed (<25th %ile)), a 0.30x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a CONSOLIDATION options structure phase (-0.77β · 61% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.